Trends in Initiation of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among Commercially Insured Adults in the United States, 2001-2021
Initiation Patterns of Disease-Modifying Therapies for Multiple Sclerosis Among US Adults and Children, 2001 Through 2020
Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease
2022 – Evaluation of Perceived Stress and Resilience Among Academic-Affiliated Pharmaceutical Industry Fellows
2022 – Three Clicks and You’re Out: Assessing the Usability of Patient Medical Information Websites Provided by Pharmaceutical Companies
2022 – Assessing Diversity in a PharmD Postgraduate Program: Rutgers Pharmaceutical Industry Fellowship (RPIF) with Pfizer
2022 – Primary and Secondary Sarcopenia: The Disease Burden, Current and Pipeline Therapies, and Unmet Needs
2022 – Pharmaceutical Industry Fellowships – Expansion of Inter-professional Training with Pharmacists and Physicians
2022 – Overcoming the Challenges of Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Systematic Literature Review
2022 – How States Have Changed Their Compounding Recommendations During the COVID-19 Pandemic in Response to Personal Protective Equipment (PPE) Shortages
2022 – Constructing a Framework to Increase Clinical Trial Diversity and Inclusion in Oncology
2022 – The Impact of COVID-19 Pandemic and Future Directions to Conduct Clinical Trials
